BHVN
Biohaven Ltd.
NYSE: BHVN · HEALTHCARE · BIOTECHNOLOGY
$9.08
-5.26% today
Updated 2026-06-05
Market cap
$1.72B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-5.57
Dividend yield
—
52W range
$7 – $19
Volume
2.2M
WallStSmart proprietary scores
23
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C4.0
Quality
C3.0
Profitability
D5.0
Valuation
C+1/9
Piotroski F-Score
Weak
-11.1
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$21.71
+139.10%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
4 Strong Buy10 Buy5 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
Insufficient data
Risks
- Piotroski 1/9 — weak financial health
- Altman Z -11.11 — distress zone
- Thin margins at 0.00%
- Negative free cash flow $-149.92M
- Debt/equity 2.16x — high leverage
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-570.28M | $-408.17M | $-846.42M | $-738.82M | $-130.53M |
| EPS | — | — | — | — | $-5.57 |
| Free cash flow | $-338.76M | $-334.77M | $-586.50M | $-610.15M | $-149.92M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Biohaven Ltd. trades at $9.08. Our Smart Value Score of 23/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score. With an Altman Z-Score of -11.11, it sits in the distress.
Frequently asked questions
What is Biohaven Ltd.'s stock price?
Biohaven Ltd. (BHVN) trades at $9.08.
Is Biohaven Ltd. overvalued?
Biohaven Ltd. carries a Smart Value Score of 23/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.
What is the price target of Biohaven Ltd. (BHVN)?
The 12-month analyst consensus target is $21.71, about 139.1% above the current $9.08. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
Altman Z-Score?
Biohaven Ltd.'s Altman Z-Score is -11.11, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio—
ROE-500.14%
Beta3.31
50D MA$9.58
200D MA$11.81
Shares out0.15B
Float0.12B
Short ratio—
Avg volume2.2M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—